The Question Is Whether To Buy Or Not To Buy Amarin Corp ADR (NASDAQ: AMRN)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

Amarin Corp ADR is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Drug Manufacturers – General industry. The current market capitalization of Amarin Corp ADR is $360.58M. A total of 1.39 million shares were traded on the day, compared to an average of 2.22M shares.

In the most recent transaction, Holt Patrick bought 14,426 shares of AMRN for 1.09 per share on Jan 22 ’24. After the transaction, the President and CEO now owns 314,426 company shares. In a previous transaction on Dec 12 ’23, Ketchum Steven B sold 34,131 shares at 0.79 per share. AMRN shares that Chief Scientific Officer owns now total 566,100.

Among the insiders who bought shares, Holt Patrick acquired of 300,000 shares on Aug 16 ’23 at a per-share price of $1.04. This resulted in the President and CEO holding 300,000 shares of AMRN after the transaction.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, AMRN has a high of $1.56 and a low of $0.65.

As of this writing, AMRN has an earnings estimate of -$0.03 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of -$0.01 per share and a lower estimate of -$0.05. The company reported an EPS of -$0.05 in the last quarter, which was -25.00% lower than expectations of -$0.04.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. AMRN’s latest balance sheet shows that the firm has $454.13M in Cash & Short Term Investments as of fiscal 2021. There were $8.58M in debt and $370.68M in liabilities at the time. Its Book Value Per Share was $1.35, while its Total Shareholder’s Equity was $667.10M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AMRN is Buy with a score of 2.60.

Most Popular

Related Posts